ArticleDiagnostics (Basel, Switzerland)2019
Prostate Artery Embolization for Lower Urinary Tract Symptoms in Men Unfit for Surgery.
Article in Diagnostics (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 21 citations in OpenAlex.
- Efficacy of High-Dose Dexamethasone in Reducing the Symptoms of Postembolization Syndrome Following Prostatic Artery Embolization: Results of a Double-Blind Randomized Controlled Trial.Cardiovascular and interventional radiology · 2024Trial
- Transcatheter Arterial Embolization for Alleviating Chronic Musculoskeletal Pain and Improving Physical Function: A Narrative Review.Diagnostics (Basel, Switzerland) · 2022Review
- Transurethral resection of the prostate in 85+ patients: a retrospective, multicentre study.World journal of urology · 2022Article
- Rezūm water vapor therapy in multimorbid patients with urinary retention and catheter dependency.Prostate cancer and prostatic diseases · 2022Article
- New Ultra-minimally Invasive Surgical Treatment for Benign Prostatic Hyperplasia: A Systematic Review and Analysis of Comparative Outcomes.European urology open science · 2021Review
- Prostate Artery Embolization-Review of Indications, Patient Selection, Techniques and Results.Journal of clinical medicine · 2021Review
- Safety and efficacy of prostatic artery embolization for large benign prostatic hyperplasia in elderly patients.The Journal of international medical research · 2021Article
- [Management of geriatric patients with benign prostatic hyperplasia].Der Urologe. Ausg. A · 2020Review
- Postembolization Syndrome after Prostatic Artery Embolization: A Systematic Review.Diagnostics (Basel, Switzerland) · 2020Review
- Can Computed Tomography Perfusion Predict Treatment Response After Prostate Artery Embolization: A Feasibility Study.Diagnostics (Basel, Switzerland) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nearly one in three men develop lower urinary tract symptoms (LUTS) and 10% clinically progress despite medication. Transurethral resection of the prostate (TURP) is the reference standard for symptoms refractory to medical treatment. However, some patients cannot tolerate TURP for medical (e.g., comorbidity) or technical (e.g., large prostate) reasons. This study estimated the safety and effect of prostate artery embolization (PAE) in men unfit for surgery. A prospective, single-centre trial including men with LUTS or urinary retention secondary to benign prostatic hyperplasia (BPH) who were unfit for surgery. The primary objective was to treat urinary retention and LUTS. Outcome measures included International Prostate Symptom Score (IPSS), quality of life (IPSS-QoL), International Index of Erectile Function (IIEF-5), prostate volume (PV), prostate-specific antigen (PSA), peak void flow (Qmax), post-void residual (PVR), and complications. A
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.